Susan Hurst

2.3k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Susan Hurst is a scholar working on Oncology, Pharmacology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susan Hurst has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pharmacology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susan Hurst's work include Pharmacogenetics and Drug Metabolism (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Susan Hurst is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Susan Hurst collaborates with scholars based in United States and United Kingdom. Susan Hurst's co-authors include Ruth Hyland, J. Andrew Williams, Dennis A. Smith, Theunis C. Goosen, S. Ball, Barry Jones, Vincent Peterkin, Jeffrey R. Koup, Cho‐Ming Loi and Ayman El‐Kattan and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Neuroscience.

In The Last Decade

Susan Hurst

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS

2004 687 citations J. Andrew Williams, Ruth Hyland et al. Drug Metabolism and Disposition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Hurst United States	18	937	587	439	241	233	32	1.7k
Jane R. Kenny United States	24	996 1.1×	707 1.2×	442 1.0×	237 1.0×	192 0.8×	58	1.8k
David R. Jones United States	19	979 1.0×	765 1.3×	576 1.3×	135 0.6×	311 1.3×	35	2.3k
Christopher R. Gibson United States	17	731 0.8×	558 1.0×	418 1.0×	273 1.1×	251 1.1×	44	1.7k
Dan A. Rock United States	28	953 1.0×	721 1.2×	633 1.4×	264 1.1×	96 0.4×	68	2.1k
Bernard P. Murray United States	24	761 0.8×	575 1.0×	540 1.2×	134 0.6×	202 0.9×	61	2.0k
Hongjian Zhang China	25	545 0.6×	693 1.2×	759 1.7×	152 0.6×	167 0.7×	90	2.1k
Cuyue Tang United States	25	839 0.9×	627 1.1×	631 1.4×	206 0.9×	213 0.9×	66	2.2k
Chuang Lu United States	23	1.1k 1.2×	748 1.3×	659 1.5×	305 1.3×	250 1.1×	56	2.3k
A. David Rodrigues United States	26	924 1.0×	772 1.3×	416 0.9×	155 0.6×	328 1.4×	49	1.8k
Liang‐Shang Gan United States	25	759 0.8×	953 1.6×	843 1.9×	223 0.9×	379 1.6×	43	2.4k

Countries citing papers authored by Susan Hurst

Since Specialization

Citations

This map shows the geographic impact of Susan Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Hurst more than expected).

Fields of papers citing papers by Susan Hurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Hurst. The network helps show where Susan Hurst may publish in the future.

Co-authorship network of co-authors of Susan Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Hurst. A scholar is included among the top collaborators of Susan Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Hurst. Susan Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peraza, Marjorie A., et al.. (2025). Marstacimab, an antitissue factor pathway inhibitor, combined with bypassing agents: effects on thrombin generation and in hemostatically normal rats. Research and Practice in Thrombosis and Haemostasis. 9(7). 103180–103180. 1 indexed citations

Peraza, Marjorie A., Susan Hurst, Wenhu Huang, et al.. (2023). Ocular Safety and Toxicokinetics of Bevacizumab-bvzr (Zirabev), a Bevacizumab Biosimilar, Administered to Cynomolgus Monkeys by Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics. 39(3). 215–224.

Walsh, Jason, et al.. (2023). Analysis of β-nerve growth factor and its precursor during human pregnancy by immunoaffinity-liquid chromatography tandem mass spectrometry. Scientific Reports. 13(1). 9180–9180. 4 indexed citations

LaBranche, Timothy P., Alison M. Bendele, Kathryn E. Gropp, et al.. (2016). Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model. Annals of the Rheumatic Diseases. 76(1). 295–302. 44 indexed citations

Bui, Lynne A., Susan Hurst, Gregory L. Finch, et al.. (2015). Key considerations in the preclinical development of biosimilars. Drug Discovery Today. 20. 3–15. 46 indexed citations

Neubert, Hendrik, Tracey Clark, Shibing Deng, & Susan Hurst. (2014). Serum β-nerve growth factor concentrations in pregnant female, nonpregnant female, and male cynomolgus monkeys. Neuroreport. 25(11). 829–832. 4 indexed citations

Bowman, Christopher, Mark G. Evans, Satoru Oneda, et al.. (2014). Developmental toxicity assessment of tanezumab, an anti-nerve growth factor monoclonal antibody, in cynomolgus monkeys (Macaca fascicularis). Reproductive Toxicology. 53. 105–118. 12 indexed citations

Hurst, Susan, Anne Ryan, James M. McNally, et al.. (2014). Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®). BioDrugs. 28(5). 451–459. 39 indexed citations

Lankford, Karen L., Edgardo J. Arroyo, Chang‐Ning Liu, et al.. (2013). Sciatic nerve regeneration is not inhibited by anti-NGF antibody treatment in the adult rat. Neuroscience. 241. 157–169. 8 indexed citations

10.

Kraynov, Eugenia, Steven W. Martin, Susan Hurst, et al.. (2011). How Current Understanding of Clearance Mechanisms and Pharmacodynamics of Therapeutic Proteins Can Be Applied for Evaluation of Their Drug-Drug Interaction Potential. Drug Metabolism and Disposition. 39(10). 1779–1783. 14 indexed citations

11.

Zorbas, Mark, Susan Hurst, David L. Shelton, et al.. (2010). A multiple-dose toxicity study of tanezumab in cynomolgus monkeys. Regulatory Toxicology and Pharmacology. 59(2). 334–342. 24 indexed citations

12.

Fahmi, Odette A., Susan Hurst, David R. Plowchalk, et al.. (2009). Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction. Drug Metabolism and Disposition. 37(8). 1658–1666. 167 indexed citations

13.

Wilson, Michael W., Paul D. Johnson, Shelley R. Graham, et al.. (2009). Synthesis and SAR of tolylamine 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(9). 2409–2412. 17 indexed citations

14.

Hurst, Susan, Cho‐Ming Loi, Joanne Brodfuehrer, & Ayman El‐Kattan. (2007). Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology. 3(4). 469–489. 74 indexed citations

15.

Goosen, Theunis C., Jonathan Bauman, John A. Davis, et al.. (2007). Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid. Drug Metabolism and Disposition. 35(8). 1315–1324. 45 indexed citations

16.

Hurst, Susan, et al.. (2005). A Case of Pulmonary Alveolar Proteinosis Treated With Whole Lung Lavage. Dimensions of Critical Care Nursing. 24(3). 120–122. 1 indexed citations

17.

Bauman, Jonathan, Theunis C. Goosen, Meera Tugnait, et al.. (2005). UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(9). 1349–1354. 16 indexed citations

18.

Williams, J. Andrew, Ruth Hyland, Barry Jones, et al.. (2004). DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS. Drug Metabolism and Disposition. 32(11). 1201–1208. 687 indexed citations breakdown →

19.

Williams, John A., Susan Hurst, Jonathan Bauman, et al.. (2003). Reaction Phenotyping in Drug Discovery: Moving Forward with Confidence?. Current Drug Metabolism. 4(6). 527–534. 39 indexed citations

20.

Williams, J. Andrew, Jack Cook, & Susan Hurst. (2003). A SIGNIFICANT DRUG-METABOLIZING ROLE FOR CYP3A5?. Drug Metabolism and Disposition. 31(12). 1526–1531. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact